Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

CRSwNP EVEREST

What makes avalglucosidase alfa different from alglucosidase alfa in terms of clinical efficacy and patient outcomes?

Advances in Therapy: Avalglucosidase Alfa & Future Innovations

Pompe Care Podcast Series 2

Thank You!

The End

How can you see changing the lives of patient starting taking Nexviazyme and if you can share from your experience couple of patient stories that realy impacted positively from staring the treatment for Pompe disease?

From your experience

What has been your experience with switching patients from alglucosidase alfa to avalglucosidase alfa?

Current Treatment Landscape & hands on Experience

What factors influence your decision to switch a patient from alglucosidase alfa to avalglucosidase alfa?

What challenges do clinicians face in monitoring in disease progrission and response to therapy?

Pompe Care Podcast Series 3

Have you observed any significant differences in treatment outcomes between these two therapies in your local practice?

How has avalglucosidase alfa impacted the treatment paradigm for both infantile-onset and late-onset Pompe disease in your experience?

Structured Monitoring for Early Detection of Fabry Progression